Max S. Cynader, CM, OBC, PhD, FRSC, FCAHS.
CEO and Co-Founder
Professor, University of British Columbia (UBC). Canada Research Chair in Brain Development. Fellow, Canadian Academy of Health Sciences & Royal Society of Canada. Founder of 4 start-ups. Sold NeuroVir, a gene therapy products company, to treat brain cancer for $140M to Medigene AG in 2001.